Skip to main content

GFS Advisors, LLC

Position in NVCR — NovoCure Ltd

CIK 1427263 HOUSTON, TX

Position in NVCR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,651
-$68,199 QoQ
Shares Held
175
-97.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#196
of 214 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

GFS Advisors, LLC holds $3,854 across 3 Medical Devices names. NVCR ranks #1 (68.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NVCR
NovoCure Ltd
This page
175 $2,651

All Filings in NVCR

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,651 175
2026-03-31 $70,850 6,500